The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

NCT06419686 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Effect of iv Administration of GIP and Alanine

Interventions

OTHER: Placebo (saline)
DRUG: GIP
DRUG: Alanine
DRUG: GIP + alanine

Sponsor

University Hospital, Gentofte, Copenhagen